Listen to expert faculty discuss how to incorporate the use of GLP-1RAs and SGLT2 inhibitors into your health care setting in a multidisciplinary way. This discussion focuses on how to identify the key team members, how to communicate effectively across the care team, and how important education is to the successful collaboration across the care team continuum.

Supplemental Slides 

Educational grant support provided by: Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC

To visit the hub for the CV Risk in Diabetes: Emerging Science Grant, click here!

Clinical Topics: Diabetes and Cardiometabolic Disease, Dyslipidemia, Prevention, Lipid Metabolism

Keywords: Primary Prevention, Diabetes Mellitus, Dyslipidemias, Sodium-Glucose Transporter 2

< Back to Listings